Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats

Endocrinology

Volumn 143, Issue 11, 2002, Pages 4397-4408

  Farilla, Loredana ^a,c   Hongxiang, Hui ^a,c   Bertolotto, Cristina ^b,c   Kang, Elizabeth ^a   Bulotta, Angela ^a   Mario, Umberto D I ^d   Perfetti, Riccardo ^a,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Division of Neonatology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DIAMINIDINO 2 PHENYL DIHYDROCHLORIDE; CELL MARKER; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DYE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; KI 67 ANTIGEN; RECOMBINANT GLUCAGON LIKE PEPTIDE 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCRINE PANCREAS FUNCTION TEST; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GROWTH INHIBITION; GROWTH REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN METABOLISM; INSULIN RELEASE; MALE; METABOLIC REGULATION; NICK END LABELING; NONHUMAN; ONSET AGE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE;

EID: 0036828227     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220405     Document Type: Article

References (22)

1. Orsakov C 1992 Glucagon-like peptide-1, a new hormone of the enteroinsular axis. Diabetologia 35:701-711
2. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W 1993 Normalization of fasting hyperglycemia by exogenous glucagon-like peptide-1 [7-36 amide] in type 2 (non-insulin dependent) diabetic patients. Diabetologia 36:741-744
3. Holst JJ 1994 Glucagon-like peptide-1 (GLP-1) a newly discovered GI hormone. Gastroenterology 107:1848-1855
4. Thorens B 1992 Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8645
5. Fehmann H-C, Goke R, Goke B 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410
6. 2+-signaling pathway in pancreatic β-cells by the insulmotropic hormone glucagon-like peptide-1. J Biol Chem 270:17749-17757
7. Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 1 and type 2 diabetic patients. Diabetes 50:609-613
8. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322
9. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W 1993 Normalization of fasting hyperglycemia by exogenous glucagon-like peptide-1 [7-36 amide] in type 2 (non-insulin dependent) diabetic patients. Diabetologia 36:741-744
10. Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Rafizadeh C 1997 Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889
11. Xu G, Stoffers DA, Habener JF, Bonner-Weir S 1999 Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276
12. Kasiske BL, O'Donnell MP, Keane WF 1992 The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19:110-115
13. Clark JB, Palmer CJ, Shaw WN 1983 The diabetic Zucker fatty rat. Exp Biol Med 173:68-75
14. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS 1998 Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358-364
15. Hui H, Farilla L, Merkel P, Perfetti R 2002 The short half-life of GLP-1 in plasma does not reflect its long-lasting biological activity. Eur J Endocrinol 146:863-869
16. Weibel ER 1978 Stereologic methods. In: Practical Methods for Biologic Morphometry. London: Academic Press; vol 1:101-161
17. Montana E, Bonner-Weir S, Weir GC 1993 β-cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C56BL/6 mice. J Clin Invest 91:780-787
18. Perfetti R, Zhou J, Doyle ME, Egan JM 2000 Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141:4600-4605
19. Trumper A, Trumper K, Trusheim H, Arnold R, Goke B, Horsch D 2001 Glucose-dependent insulmotropic polypeptide is a growth factor for β (INS-1) cells by pleitropic signaling. Mol Endocrinol 15:1559-1570
20. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S 1997 Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741
21. Mandrup-Poulsen T 2001 β-cell apoptosis: Stimuli and signaling. Diabetes 50(Suppl 1):S58-S63
22. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE 2001 β-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50:1021-1029